Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001829126-24-007763
Filing Date
2024-11-22
Accepted
2024-11-22 16:05:25
Documents
23
Period of Report
2024-11-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A zeoscientifix_8ka.htm   iXBRL 8-K/A 33029
2 EXHIBIT 99.1 zeoscientifix_ex99-1.htm EX-99.1 10424
3 GRAPHIC ex99-1_001.jpg GRAPHIC 237987
4 GRAPHIC ex99-1_002.jpg GRAPHIC 630969
5 GRAPHIC ex99-1_003.jpg GRAPHIC 399268
6 GRAPHIC ex99-1_004.jpg GRAPHIC 389513
7 GRAPHIC ex99-1_005.jpg GRAPHIC 222183
8 GRAPHIC ex99-1_006.jpg GRAPHIC 455977
9 GRAPHIC ex99-1_007.jpg GRAPHIC 527756
10 GRAPHIC ex99-1_008.jpg GRAPHIC 571544
11 GRAPHIC ex99-1_009.jpg GRAPHIC 449335
  Complete submission text file 0001829126-24-007763.txt   5265172

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE ocel-20241115.xsd EX-101.SCH 2991
13 XBRL LABEL FILE ocel-20241115_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE ocel-20241115_pre.xml EX-101.PRE 22343
25 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8ka_htm.xml XML 4445
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K/A | Act: 34 | File No.: 000-55008 | Film No.: 241489702
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)